These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3318704)

  • 1. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment].
    Shitara N; Nakamura H; Genka S; Takakura K
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3235-44. PubMed ID: 3318704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances of BRM therapy of malignant brain tumors].
    Nagai M
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):188-94. PubMed ID: 1992912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of interferon therapy on malignant brain tumor].
    Nagai M; Arai T; Kohno S; Iizuka E
    Gan No Rinsho; 1983 May; 29(6):608-15. PubMed ID: 6876429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of human fibroblast interferon on malignant brain tumors].
    Nakamura O; Teramoto A; Yamamoto H; Ochiai C; Takakura K; Maruo K; Ueyama Y; Shimamura K
    No To Shinkei; 1983 Sep; 35(9):905-11. PubMed ID: 6651989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adoptive immunotherapy in patients with medulloblastoma by LAK cells].
    Shimizu K; Tamura K; Yamada M; Okamoto Y; Miyao Y; Park K; Matsui Y; Hayakawa T; Takimoto H; Mogami H
    No To Shinkei; 1989 Oct; 41(10):991-5. PubMed ID: 2605046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and adverse effects of beta-interferon in the treatment of malignant glioma].
    Oda Y; Konishi T; Suzui H; Kamijo Y; Kang Y; Okumura T; Kaneko T; Kikuchi H
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2411-7. PubMed ID: 2614179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous natural killer cell therapy for human recurrent malignant glioma.
    Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
    Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.
    Jacobs SK; Wilson DJ; Kornblith PL; Grimm EA
    Cancer Res; 1986 Apr; 46(4 Pt 2):2101-4. PubMed ID: 3512079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of interferon on malignant brain tumor].
    Wakabayashi T; Yoshida J; Kobayashi T; Kageyama N; Kanzaki M
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1400-6. PubMed ID: 7184455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local application of interferon to malignant brain tumors.
    Nagai M; Arai T; Kohno S; Kohase M
    Tex Rep Biol Med; 1981-1982; 41():693-8. PubMed ID: 7052705
    [No Abstract]   [Full Text] [Related]  

  • 11. Local administration of interferon for malignant brain tumors.
    Nakagawa Y; Hirakawa K; Ueda S; Suzuki K; Fukuma S; Kishida T; Imanishi J; Amagai T
    Cancer Treat Rep; 1983 Sep; 67(9):833-5. PubMed ID: 6688376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy with IFN-beta, ACNU and radiation (IAR) in malignant brain tumors].
    Yoshida J; Wakabayashi T; Kato K; Enomoto H; Kito A; Kageyama N
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):520-4. PubMed ID: 3456740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with stimulated autologous lymphocytes in a case of a juvenile anaplastic glioma.
    Thomas C; Schober R; Lenard HG; Lumenta CB; Jacques DB; Wechsler W
    Neuropediatrics; 1992 Jun; 23(3):123-5. PubMed ID: 1641079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on the treatment of recurrent gliomas].
    Yamada M; Shimizu K; Okamoto Y; Miyao Y; Matsui Y; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1890-5. PubMed ID: 3496051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effect of human fibroblast interferon (BM532) on malignant brain tumors--with special reference to gliomas].
    Nagai M
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):638-46. PubMed ID: 2671205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):913-20. PubMed ID: 3885862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes.
    Kimoto Y; Taguchi T
    Biken J; 1987 Jun; 30(2):29-38. PubMed ID: 3501954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trials of interferon-beta (MR-21) on malignant brain tumors].
    Takakura K
    Nihon Gan Chiryo Gakkai Shi; 1987 May; 22(4):801-8. PubMed ID: 3312440
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
    Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.